|
1
|
Zhu N, Zhang D, Wang W, Li X, Yang B, Song
J, Zhao X, Huang B, Shi W, Lu R, et al: A novel coronavirus from
patients with Pneumonia in China, 2019. N Engl J Med. 382:727–733.
2020.PubMed/NCBI View Article : Google Scholar
|
|
2
|
World Health Organization (WHO): Rolling
updates on coronavirus disease (COVID-19). In: Events as they
happen. World Health Organization, Geneva, Switzerland, 2020.
|
|
3
|
World Health Organization (WHO): Novel
Coronavirus (COVID-19). In: Situation reports. World Health
Organization, Geneva, Switzerland, 2020.
|
|
4
|
Epidemiology Working Group for NCIP
Epidemic Response, Chinese Center for Disease Control and
Prevention. The epidemiological characteristics of an outbreak of
2019 novel coronavirus diseases (COVID-19) in China. Zhonghua Liu
Xing Bing Xue Za Zhi. 41:145–151. 2020.PubMed/NCBI View Article : Google Scholar : (In Chinese).
|
|
5
|
Wu Z and McGoogan JM: Characteristics of
and important lessons from the coronavirus disease 2019 (COVID-19)
outbreak in China: Summary of a Report of 72 314 cases from the
Chinese center for disease control and prevention. JAMA.
323:1239–1242. 2020.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Cevik M, Kuppalli K, Kindrachuk J and
Peiris M: Virology, transmission, and pathogenesis of SARS-CoV-2.
BMJ. 371(m3862)2020.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Henry B, Cheruiyot I, Vikse J, Mutua V,
Kipkorir V, Benoit J, Plebani M, Bragazzi N and Lippi G:
Lymphopenia and neutrophilia at admission predicts severity and
mortality in patients with COVID-19: A meta-analysis. Acta Biomed.
91(e2020008)2020.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J,
Wang B, Xiang H, Cheng Z, Xiong Y, et al: Clinical characteristics
of 138 hospitalized patients with 2019 novel coronavirus-infected
Pneumonia in Wuhan, China. JAMA. 323:1061–1069. 2020.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Zaim S, Chong JH, Sankaranarayanan V and
Harky A: COVID-19 and multiorgan response. Curr Probl Cardiol.
45(100618)2020.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Wiersinga WJ, Rhodes A, Cheng AC, Peacock
SJ and Prescott HC: Pathophysiology, transmission, diagnosis, and
treatment of coronavirus disease 2019 (COVID-19): A review. JAMA.
324:782–793. 2020.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Tian W, Jiang W, Yao J, Nicholson CJ, Li
RH, Sigurslid HH, Wooster L, Rotter JI, Guo X and Malhotra R:
Predictors of mortality in hospitalized COVID-19 patients: A
systematic review and meta-analysis. J Med Virol. 92:1875–1883.
2020.PubMed/NCBI View Article : Google Scholar
|
|
12
|
ARDS Definition Task Force. Ranieri VM,
Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E, Fan E,
Camporota L and Slutsky AS: Acute respiratory distress syndrome:
The Berlin definition. JAMA. 307:2526–2533. 2012.PubMed/NCBI View Article : Google Scholar
|
|
13
|
World Medical Association. World Medical
Association Declaration of Helsinki: Ethical principles for medical
research involving human subjects. JAMA. 310:2191–2194.
2013.PubMed/NCBI View Article : Google Scholar
|
|
14
|
RStudio Team: Integrated development for
R. RStudio, Inc., Boston MA, 2015. http://www.rstudio.com/.
|
|
15
|
Inciardi RM, Adamo M, Lupi L, Cani DS, Di
Pasquale M, Tomasoni D, Italia L, Zaccone G, Tedino C, Fabbricatore
D, et al: Characteristics and outcomes of patients hospitalized for
COVID-19 and cardiac disease in Northern Italy. Eur Heart J.
41:1821–1829. 2020.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Iaccarino G, Grassi G, Borghi C, Ferri C,
Salvetti M and Volpe M: SARS-RAS Investigators. Age and
Multimorbidity Predict Death Among COVID-19 Patients: Results of
the SARS-RAS Study of the Italian Society of Hypertension.
Hypertension. 76:366–372. 2020.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Richardson S, Hirsch JS, Narasimhan M,
Crawford JM, McGinn T and Davidson KW: The Northwell COVID-19
Research Consortium. Barnaby DP, Becker LB, Chelico JD, et al:
Presenting characteristics, comorbidities, and outcomes among 5700
patients hospitalized with COVID-19 in the New York City Area.
JAMA. 323:2052–2059. 2020.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Giacomelli A, Ridolfo AL, Milazzo L, Oreni
L, Bernacchia D, Siano M, Bonazzetti C, Covizzi A, Schiuma M,
Passerini M, et al: 30-day mortality in patients hospitalized with
COVID-19 during the first wave of the Italian epidemic: A
prospective cohort study. Pharmacol Res. 158(104931)2020.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Wu C, Chen X, Cai Y, Xia J, Zhou X, Xu S,
Huang H, Zhang L, Zhou X, Du C, et al: Risk factors associated with
acute respiratory distress syndrome and death in patients with
coronavirus disease 2019 Pneumonia in Wuhan, China. JAMA Intern
Med. 180:934–943. 2020.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z,
Xiang J, Wang Y, Song B, Gu X, et al: Clinical course and risk
factors for mortality of adult inpatients with COVID-19 in Wuhan,
China: A retrospective cohort study. Lancet. 395:1054–1062.
2020.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Wenham C, Smith J and Morgan R: Gender and
COVID-19 Working Group. COVID-19: The gendered impacts of the
outbreak. Lancet. 395:846–848. 2020.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Yang J, Zheng Y, Gou X, Pu K, Chen Z, Guo
Q, Ji R, Wang H, Wang Y and Zhou Y: Prevalence of comorbidities and
its effects in patients infected with SARS-CoV-2: A systematic
review and meta-analysis. Int J Infect Dis. 94:91–95.
2020.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Ceccarelli M, Marino A, Cosentino F,
Moscatt V, Celesia BM, Gussio M, Bruno R, Rullo EV, Nunnari G and
Cacopardo BS: Post-infectious ST elevation myocardial infarction
following a COVID-19 infection: A case report. Biomed Rep.
16(10)2022.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Gold MS, Sehayek D, Gabrielli S, Zhang X,
McCusker C and Ben-Shoshan M: COVID-19 and comorbidities: A
systematic review and meta-analysis. Postgrad Med. 132:749–755.
2020.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Mantovani A, Byrne CD, Zheng MH and
Targher G: Diabetes as a risk factor for greater COVID-19 severity
and in-hospital death: A meta-analysis of observational studies.
Nutr Metab Cardiovasc Dis. 30:1236–1248. 2020.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Ejaz H, Alsrhani A, Zafar A, Javed H,
Junaid K, Abdalla AE, Abosalif KOA, Ahmed Z and Younas S: COVID-19
and comorbidities: Deleterious impact on infected patients. J
Infect Public Health. 13:1833–1839. 2020.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Luo X, Zhou W, Yan X, Guo T, Wang B, Xia
H, Ye L, Xiong J, Jiang Z, Liu Y, et al: Prognostic Value of
C-Reactive Protein in Patients with Coronavirus 2019. Clin Infect
Dis. 71:2174–2179. 2020.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Shah VK, Firmal P, Alam A, Ganguly D and
Chattopadhyay S: Overview of immune response during SARS-CoV-2
infection: Lessons from the past. Front Immunol.
11(1949)2020.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Liu J, Liu Y, Xiang P, Pu L, Xiong H, Li
C, Zhang M, Tan J, Xu Y, Song R, et al: Neutrophil-to-lymphocyte
ratio predicts critical illness patients with 2019 coronavirus
disease in the early stage. J Transl Med. 18(206)2020.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Vitacca M, Nava S, Santus P and Harari S:
Early consensus management for non-ICU acute respiratory failure
SARS-CoV-2 emergency in Italy: From ward to trenches. Eur Respir J.
55(2000632)2020.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Ashish A, Unsworth A, Martindale J, Sundar
R, Kavuri K, Sedda L and Farrier M: CPAP management of COVID-19
respiratory failure: A first quantitative analysis from an
inpatient service evaluation. BMJ Open Respir Res.
7(e000692)2020.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Rochwerg B, Granton D, Wang DX, Helviz Y,
Einav S, Frat JP, Mekontso-Dessap A, Schreiber A, Azoulay E, Mercat
A, et al: High flow nasal cannula compared with conventional oxygen
therapy for acute hypoxemic respiratory failure: A systematic
review and meta-analysis. Intensive Care Med. 45:563–572.
2019.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Li J, Fink JB and Ehrmann S: High-flow
nasal cannula for COVID-19 patients: Low risk of bio-aerosol
dispersion. Eur Respir J. 55(2000892)2020.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Marino A, Pampaloni A, Scuderi D,
Cosentino F, Moscatt V, Ceccarelli M, Gussio M, Celesia BM, Bruno
R, Borraccino S, et al: High-flow nasal cannula oxygenation and
tocilizumab administration in patients critically ill with
COVID-19: A report of three cases and a literature review. World
Acad Sci J. 2(23)2020.
|
|
35
|
Marino A, Cosentino F, Pampaloni A,
Scuderi D, Moscatt V, Ceccarelli M, Gussio M, Onorante A, Zagami A,
Torrisi S, et al: Role of tocilizumab and high flow nasal cannula
in the clinical management of severe covid-19. J Clin Trials.
10(427)2020.
|
